COLL vs TEAM · P/E 17, rev $181.9M vs rev $6.57B
Collegium Pharmaceutical Inc (COLL) versus Atlassian Corp Plc (TEAM) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Atlassian Corp Plc (TEAM) is a software - application company listed on NASDAQ. It is led by Mike Cannon-Brookes.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported TEAM revenue for 2026-06-30 was $6.57B. Net income was -$53.8M. Revenue was up 26.0% from 2025-06-30 to 2026-06-30. TEAM currently screens at market cap $22.01B.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. TEAM currently screens at market cap $22.01B.
Not investment advice. Open the COLL and TEAM stock pages for the full models.
Not investment advice.